Parse Biosciences

Parse Biosciences is a life sciences company based in Seattle, Washington, focused on scalable, instrument-free single-cell sequencing solutions. Founded in 2018, the company aims to enhance human health and scientific research by providing researchers with the tools to perform single-cell sequencing efficiently and flexibly. Parse serves over 3,000 customers in more than 40 countries and has raised over $100 million in funding. The company offers a range of services, including a chemistry-base